MDMA and MDA concentrations in antemortem and postmortem specimens in fatalities following hospital admission

Journal of Analytical Toxicology

Volumn 29, Issue 5, 2005, Pages 296-300

  Elliott, Simon P ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; BENZOYLECGONINE; CHLORDIAZEPOXIDE;

ADULT; AUTOPSY; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG SCREENING; FATALITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL ADMISSION; HUMAN; INTOXICATION; MALE; MALIGNANT HYPERTHERMIA;

EID: 23944444518     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.5.296     Document Type: Conference Paper

References (20)

1. J.V. Pham and T. Puzantian. Ecstasy: dangers and controversies. Pharmacotherapy 21(12): 1561-1565 (2001).
2. C.M. Milroy. Ten years of 'ecstasy'. J. R. Soc. Med. 92(2): 68-71 (1999).
3. H. Kalant. The pharmacology and toxicology of "Ecstasy" (MDMA) and related drugs. Can. Med. Assoc. J. 165(7): 917-928 (2001).
4. J.A. Henry, K.J. Jeffreys, and S. Dawling. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("Ecstasy"). Lancet 340(8816): 384-387 (1992).
5. S.J. Lester, M. Baggott, S. Welm, N.B. Schiller, R.T. Jones, E. Foster, and J. Mendelson. Cardiovasular effects of 3,4-methylenedioxymethamphetamine. A double-blind placebo controlled trial. Ann. Intern. Med. 133(12): 969-973 (2000).
6. L.A. Badon, A. Hicks, K. Lord, B.A. Ogden, S. Meleg-Smith, and K.J. Varner. Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy. J. Pharmacol. Exp. Ther. 302(3): 898-907 (2002).
7. R. de La Torre, M. Farre, J. Ortuno, M. Mas, R. Brenneisen, P.M. Roset, J. Segura, and J. Cami. Non-linear pharmacokinetics of MDMA ("Ecstasy" ) in humans. Brit. J. Clin. Pharm. 49: 104-109 (2000).
8. H.-J. Helmlin, K. Bracher, D. Bourquin, D. Vonlanthen, and R. Brenneisen. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS. J. Anal. Toxicol. 20: 432-440 (1996).
9. G.W. Kunsman, B. Levine, J.J. Kuhlman, R. L. Jones, R.O. Hughes, C.I. Fujiyama, and M.L. Smith. MDA-MDMA concentrations in urine specimens. J. Anal. Toxicol. 20: 517-521 (1996).
10. R.C. Baselt. Methylenedioxymethamphetamine. In Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Biomedical Publications, Foster City, CA, 2002, pp 687-689.
11. A.C. Moffat, M.D. Osselton, and B. Widdop. Methyle-nedioxymethamfetamine. In Clarkes' Analysis of Drugs and Poisons, 3rd ed. Pharmaceutical Press, London, U.K., 2004, pp 1256-1258.
12. T. Hilberg, S. Rogde, and J. Morland. Postmortem drug redistribution-human cases related to results in experimental animals. J. Forensic Sci. 44(1): 3-9 (1999).
13. T. Miyazaki, T. Kojima, M. Yashiki, H. Wakamoto, Y. Iwasaki, and T. Taniguchi. Site dependence of methamphetamine concentrations in blood samples collected from cadavers of people who had been methamphetamine abusers. Am. J. Forensic Med. Pathol. 14(2): 121-124 (1993)
14. T.L. Martin. Three cases of fatal paramethoxyamphetamine overdose. J. Anal. Toxicol. 25(7): 649-651 (2001).
15. T.P. Rohrig and R.W. Prouty. Tissue distribution of methyle- nedioxymethamphetamine. J. Anal. Toxicol. 16(1): 52-53 (1992).
16. E.A. De Letter, K.M. Clauwaert, W.E. Lambert, J.F. Van Bocxlaer, A.P. De Leenheer, and M.H. Piette. Distribution study of 3,4- methylenedioxymethamphetamine and 3,4-methylenedioxy-amphetamine in a fatal overdose. J. Anal. Toxicol. 26(2): 113-118 (2002).
17. R. Dams, E.A. De Letter, K.A. Mortier, J.A. Cordonnier, W.E. Lambert, M.H. Piette, S. Van Calenbergh, and A.P. De Leenheer. Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study. J. Anal. Toxicol. 27(5): 318-322 (2003).
18. S.P. Elliott. Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA). J. Anal. Toxicol. 24: 85-89 (2000).
19. E.A. De Letter, M.P. Bouche, J.F. Van Bocxlaer, W.E. Lambert, and M.H. Piette. Interpretation of a 3,4-methylenedioxy-methamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. Forensic Sci. Int. 141(2-3): 85-90 (2004).
20. E.A. De Letter, P. De Paepe, K.M. Clauwaert, F.M. Belpaire, W.E. Lambert, J.F. Van Bocxlaer, and M.H. Piette. Is vitreous humour useful for the interpretation of 3,4-methylenedioxy-methamphetamine (MDMA) blood levels? Experimental approach with rabbits. Int. J. Legal Med. 114(1-2): 29-35 (2000).